Cover Image
市場調查報告書

Molecular Targeting Technologies, Inc. : 產品平台分析

Molecular Targeting Technologies, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 253785
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Molecular Targeting Technologies, Inc. : 產品平台分析 Molecular Targeting Technologies, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 24 Pages
簡介

Molecular Targeting Technologies Inc. 是開發用於循環系統疾病和腫瘤診斷及治療上的影像診斷設備之生物科技企業。

本報告提供Molecular Targeting Technologies, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Molecular Targeting Technologies, Inc.的基本資料

  • Molecular Targeting Technologies, Inc.概要
  • 主要資訊
  • 企業資料

Molecular Targeting Technologies, Inc.:R&D概要

  • 主要的治療範圍

Molecular Targeting Technologies, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Molecular Targeting Technologies, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Molecular Targeting Technologies, Inc.:藥物簡介

  • SO-57
  • SOJB
  • botulinum vaccine
  • rabies vaccine
  • SMDC-T1

Molecular Targeting Technologies, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Molecular Targeting Technologies, Inc.:最近的開發平台趨勢

Molecular Targeting Technologies, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07467CDB

Summary

Global Markets Direct's, 'Molecular Targeting Technologies, Inc. - Product Pipeline Review - 2015', provides an overview of the Molecular Targeting Technologies, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Molecular Targeting Technologies, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Molecular Targeting Technologies, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Molecular Targeting Technologies, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Molecular Targeting Technologies, Inc.'s pipeline products

Reasons to buy

  • Evaluate Molecular Targeting Technologies, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Molecular Targeting Technologies, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Molecular Targeting Technologies, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Molecular Targeting Technologies, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Molecular Targeting Technologies, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Molecular Targeting Technologies, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Molecular Targeting Technologies, Inc. Snapshot
    • Molecular Targeting Technologies, Inc. Overview
    • Key Information
    • Key Facts
  • Molecular Targeting Technologies, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Molecular Targeting Technologies, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Molecular Targeting Technologies, Inc. - Pipeline Products Glance
    • Molecular Targeting Technologies, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Molecular Targeting Technologies, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Molecular Targeting Technologies, Inc. - Drug Profiles
    • SO-57
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SOJB
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • botulinum vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • rabies vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SMDC-T1
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Molecular Targeting Technologies, Inc. - Pipeline Analysis
    • Molecular Targeting Technologies, Inc. - Pipeline Products by Target
    • Molecular Targeting Technologies, Inc. - Pipeline Products by Route of Administration
    • Molecular Targeting Technologies, Inc. - Pipeline Products by Molecule Type
    • Molecular Targeting Technologies, Inc. - Pipeline Products by Mechanism of Action
  • Molecular Targeting Technologies, Inc. - Recent Pipeline Updates
  • Molecular Targeting Technologies, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Molecular Targeting Technologies, Inc., Key Information
  • Molecular Targeting Technologies, Inc., Key Facts
  • Molecular Targeting Technologies, Inc. - Pipeline by Indication, 2015
  • Molecular Targeting Technologies, Inc. - Pipeline by Stage of Development, 2015
  • Molecular Targeting Technologies, Inc. - Monotherapy Products in Pipeline, 2015
  • Molecular Targeting Technologies, Inc. - Phase II, 2015
  • Molecular Targeting Technologies, Inc. - Preclinical, 2015
  • Molecular Targeting Technologies, Inc. - Pipeline by Target, 2015
  • Molecular Targeting Technologies, Inc. - Pipeline by Route of Administration, 2015
  • Molecular Targeting Technologies, Inc. - Pipeline by Molecule Type, 2015
  • Molecular Targeting Technologies, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Molecular Targeting Technologies, Inc. - Recent Pipeline Updates, 2015

List of Figures

  • Molecular Targeting Technologies, Inc. - Pipeline by Top 10 Indication, 2015
  • Molecular Targeting Technologies, Inc. - Pipeline by Stage of Development, 2015
  • Molecular Targeting Technologies, Inc. - Monotherapy Products in Pipeline, 2015
  • Molecular Targeting Technologies, Inc. - Pipeline by Top 10 Target, 2015
  • Molecular Targeting Technologies, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top